Overview

OPTIMA-TBI Pilot Study

Status:
Completed

Trial end date:
2021-07-27

Target enrollment:

Participant gender:

Summary

This is a double-blind, randomized controlled trial comparing the effect of omega-3 fatty acid versus placebo on blood biomarkers of brain injury, inflammation and neurogenesis.

Phase:

Phase 2

Details

Lead Sponsor:

University of Michigan